BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 17023556)

  • 1. TLR7/8 agonists impair monocyte-derived dendritic cell differentiation and maturation.
    Assier E; Marin-Esteban V; Haziot A; Maggi E; Charron D; Mooney N
    J Leukoc Biol; 2007 Jan; 81(1):221-8. PubMed ID: 17023556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells.
    Smits EL; Cools N; Lion E; Van Camp K; Ponsaerts P; Berneman ZN; Van Tendeloo VF
    Cancer Immunol Immunother; 2010 Jan; 59(1):35-46. PubMed ID: 19449004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of 8-oxoadenines with toll-like-receptor 7 and 8 activity.
    Bazin HG; Bess LS; Livesay MT; Li Y; Cybulski V; Miller SM; Johnson DA; Evans JT
    Bioorg Med Chem Lett; 2020 Mar; 30(6):126984. PubMed ID: 32001135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-Like Receptors 7/8: A Paradigm for the Manipulation of Immunologic Reactions for Immunotherapy.
    Li F; Song B; Zhou WF; Chu LJ
    Viral Immunol; 2023 Nov; 36(9):564-578. PubMed ID: 37751284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pillars Article: Differentiation of Monocytes into Dendritic Cells in a Model of Transendothelial Trafficking.
    Randolph GJ; Beaulieu S; Lebecque S; Steinman RM; Muller WA
    J Immunol; 2017 Jun; 198(11):4191-4194. PubMed ID: 28533281
    [No Abstract]   [Full Text] [Related]  

  • 6. Structural Optimization and Biological Evaluation of Isoxazolo[5,4
    Strašek Benedik N; Dolšak A; Švajger U; Sosič I; Gobec S; Sova M
    ACS Omega; 2024 Jan; 9(2):2362-2382. PubMed ID: 38250345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation.
    Hackstein H; Knoche A; Nockher A; Poeling J; Kubin T; Jurk M; Vollmer J; Bein G
    Cell Immunol; 2011; 271(2):401-12. PubMed ID: 21889130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation.
    Larangé A; Antonios D; Pallardy M; Kerdine-Römer S
    J Leukoc Biol; 2009 Apr; 85(4):673-83. PubMed ID: 19164127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte regulation by gut microbial signals.
    Kolypetri P; Weiner HL
    Trends Microbiol; 2023 Oct; 31(10):1044-1057. PubMed ID: 37271658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of TLR7 in
    Feng Y; Xie H; Shi F; Chen D; Xie A; Li J; Fang C; Wei H; Huang H; Pan X; Tang X; Huang J
    Front Cell Infect Microbiol; 2021; 11():754299. PubMed ID: 34692568
    [No Abstract]   [Full Text] [Related]  

  • 11. Extracellular Vesicles Derived Human-miRNAs Modulate the Immune System in Type 1 Diabetes.
    Tesovnik T; Kovač J; Pohar K; Hudoklin S; Dovč K; Bratina N; Trebušak Podkrajšek K; Debeljak M; Veranič P; Bosi E; Piemonti L; Ihan A; Battelino T
    Front Cell Dev Biol; 2020; 8():202. PubMed ID: 32296701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TLR7 ligand R848 prevents mouse graft-
    Gaignage M; Marillier RG; Cochez PM; Dumoutier L; Uyttenhove C; Coutelier JP; Van Snick J
    Haematologica; 2019 Feb; 104(2):392-402. PubMed ID: 30213828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct and Intestinal Epithelial Cell-Mediated Effects of TLR8 Triggering on Human Dendritic Cells, CD14
    Angelini C; Varano B; Puddu P; Fiori M; Baldassarre A; Masotti A; Gessani S; Conti L
    Front Immunol; 2017; 8():1813. PubMed ID: 29312324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse nidovirus LDV infection alleviates graft versus host disease and induces type I IFN-dependent inhibition of dendritic cells and allo-responsive T cells.
    Gaignage M; Marillier RG; Uyttenhove C; Dauguet N; Saxena A; Ryffel B; Michiels T; Coutelier JP; Van Snick J
    Immun Inflamm Dis; 2017 Jun; 5(2):200-213. PubMed ID: 28474504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell Signaling Pathways That Regulate Antigen Presentation.
    Brutkiewicz RR
    J Immunol; 2016 Oct; 197(8):2971-2979. PubMed ID: 27824592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triggering through NOD-2 Differentiates Bone Marrow Precursors to Dendritic Cells with Potent Bactericidal activity.
    Khan N; Aqdas M; Vidyarthi A; Negi S; Pahari S; Agnihotri T; Agrewala JN
    Sci Rep; 2016 Jun; 6():27263. PubMed ID: 27265209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect between amoxicillin and TLR ligands on dendritic cells from amoxicillin-delayed allergic patients.
    Sanchez-Quintero MJ; Torres MJ; Blazquez AB; Gómez E; Fernandez TD; Doña I; Ariza A; Andreu I; Melendez L; Blanca M; Mayorga C
    PLoS One; 2013; 8(9):e74198. PubMed ID: 24066120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-talk between cd1d-restricted nkt cells and γδ cells in t regulatory cell response.
    Liu W; Huber SA
    Virol J; 2011 Jan; 8():32. PubMed ID: 21255407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Toll-like receptor 7/8 enhances uptake of apoptotic leukemic cells by monocyte-derived dendritic cells but interferes with subsequent cytokine-induced maturation.
    van den Ancker W; van Luijn MM; Ruben JM; Westers TM; Bontkes HJ; Ossenkoppele GJ; de Gruijl TD; van de Loosdrecht AA
    Cancer Immunol Immunother; 2011 Jan; 60(1):37-47. PubMed ID: 20859626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the immunopotency of Toll-like receptor agonists in an in vitro tissue-engineered immunological model.
    Ma Y; Poisson L; Sanchez-Schmitz G; Pawar S; Qu C; Randolph GJ; Warren WL; Mishkin EM; Higbee RG
    Immunology; 2010 Jul; 130(3):374-87. PubMed ID: 20331478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.